search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
133 new news items in the last 24 hours
  1. Home
  2. Health

An experimental vaccine is being tested on humans to 'reset' the immune system, having potential in combating cancer, HIV, and dementia.

Sanziana Georgescu
whatsapp
facebook
linkedin
x
copy-link copy-link
19 June 2026, 09:01
main event image
Health
Unsplash
google-preference

Always see our news on Google

Researchers have begun testing on humans of an experimental vaccine aimed at 'resetting' the immune system.


This innovation could open new perspectives in the fight against serious diseases such as cancer, HIV, and dementia. Preliminary studies suggest that the vaccine could help the body recognize and more effectively combat diseased cells.


In the context where current treatments for these conditions are often limited, the discovery of this vaccine could revolutionize therapeutic approaches. Researchers are optimistic about future results, and the success of this study could have a significant impact on public health.


Clinical trials are underway, and the scientific community is eagerly awaiting the results.

Sources

sursa imagine
Cotidianul
Vaccin revoluționar testat în premieră. Cercetătorii încearcă să „reseteze” sistemul imunitar pentru a combate cancerul, HIV și demența
sursa imagine
Stirile ProTV
Un nou vaccin care „întinerește” sistemul imunitar. Sunt vizate cancerul, HIV-ul și demența
sursa imagine
Ziare.com
Vaccinul care promite să "întinerească" sistemul imunitar intră în primul studiu pe oameni. Ar putea schimba lupta cu cancerul, demența și HIV
sursa imagine
News.ro
În premieră, un vaccin experimental pentru resetarea sistemului imunitar, testat pentru cancer, HIV şi demenţă

Latest News

16:27

Prime Minister Luca Niculescu attended a lunch hosted by the Custodian of the Crown, Margareta, and Prince Radu

16:16

ISJ Tulcea demands explanations from the Agricultural High School after an “anti-drug campaign” organized by AUR members during a break

16:08

Judges and former judges react after Nicușor Dan said that he is the “head of the Romanian state apparatus”

16:08

The Kremlin makes the presence of EU representatives at peace negotiations for Ukraine conditional on learning the Europeans’ “true intentions”

16:04

The Ministry of Education proposes annual assessments, teacher training, and activities for students as part of an anti-radicalization plan

See more news

NEWS ON THE SAME TOPICS

event image
International
An experimental cancer vaccine, developed by Moderna and Merck, has shown promising results in patients with melanoma.
event image
Health
Moderna and Merck announce promising results for the personalized vaccine against melanoma recurrence
event image
Health
Alzheimer’s drug tested on people without symptoms. Researchers want to find out whether the disease can be prevented
event image
International
Russia will use the CaTeVac vaccine from 2027 to treat sarcomas
event image
EU
The EU–Africa Partnership is providing more than €64 million to fund five networks aimed at speeding up clinical trials during epidemics
event image
IT&C knowledge
Sergiu Pașca, Romanian physician and researcher, reconstructed the cerebral cortex of mice using human neurons
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
Vaccine experimental vaccine HIV cancer dementia

Editor’s Recommendations

main event image
International
3 hours ago

What we know so far about the global Microsoft outage. OpenAI and Anthropic affected

main event image
Exclusive
3 hours ago

ANALYSIS Nvidia licenses for China: from a donation for the White House ballroom to allegations of political influence

main event image
Opinions
Yesterday 09:38

Andrei Cornea: Forget Machiavelli!

main event image
Politics
6 hours ago

INSCOP Director Remus Ștefureac announces Nicușor Dan’s level of trust in opinion polls: “Such a figure has nothing to do with reality”

Sources
imagine sursa
main event image
Exclusive
24 minutes ago

SPECIAL Informat.ro / Romania in the European press: Top topics from the past two weeks. Security in the Black Sea remains in the spotlight of European publications

main event image
Exclusive
5 hours ago

EXCLUSIV E-TRENDS by NewsVibe. The ranking of trending economic topics over the past week / Jensen Huang and the scandal at Nvidia in the spotlight

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol